Showing results (61-70 of 260) with videos related to

Sort By:
Pageof 26
Clinical Pharmacokinetics|October 31, 2021
Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital DeficiencyPier Giorgio Cojutti, Ezio Zanon, Samantha Pasca, et al.
Pharmacoepidemiology and Drug Safety|May 18, 2016
Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs?Piergiorgio Cojutti, Luca Arnoldo, Giovanni Cattani, et al.
Expert Opinion on Biological Therapy|March 15, 2018
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment?Brunella Posteraro, Federico Pea, Luca Masucci, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 10, 2017
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infectionsMatteo Bassetti, Davide Pecori, Piergiorgio Cojutti, et al.
Journal of Global Antimicrobial Resistance|May 19, 2018
Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?Piergiorgio Cojutti, Assunta Sartor, Matteo Bassetti, et al.
Expert Review of Anti-Infective Therapy|September 28, 2019
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infectionsRenato Pascale, Maddalena Giannella, Michele Bartoletti, et al.
Journal of Public Health Research|January 14, 2017
Monitoring Polypharmacy in Healthcare Systems Through a Multi-Setting Survey: Should We Put More Attention on Long Term Care Facilities?Luca Arnoldo, Giovanni Cattani, Piergiorgio Cojutti, et al.
Clinical Pharmacokinetics|March 17, 2018
Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing RegimensThomas Tängdén, Pier Giorgio Cojutti, Jason A Roberts, et al.
International Journal of Antimicrobial Agents|December 7, 2023
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysisMilo Gatti, Federica Cosentino, Maddalena Giannella, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2006
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspectiveFederico Pea, Donatella Poz, Pierluigi Viale, et al.
Pageof 26